A recent article on Kaiser Health News reported on a new drug for the treatment of hepatitis C for which the manufacturer charges $1,000 a pill, or $84,000 for a 12-week course of treatment.... Read more
Enter your email address to subscribe to Innovation Toronto and receive notifications of new posts by email.
Join 1,560 other subscribers
Anything in here will be replaced on browsers that support the canvas element
Copyright 2021 Innovation Toronto